Literature DB >> 856653

Extraction, gel filtration pattern, and receptor binding of porcine gastrointestinal glucagon-like immunoreactivity.

J J Holst.   

Abstract

Different techniques for the extraction and initial purification of porcine gastrointestinal glucagon-like immunoreactivity (GLI) were compared with reference to yield, and preservation of number and pattern of GLI components. The conventional acid-ethanol technique combined with ethanol-ether purification gave high yields and a reproducible pattern of components. Large amounts of tissue were more easily extracted using another technique, based on extraction by boiling, extraction and precipitation with acetone, and--if necessary--salting out. By means of the latter two techniques mucosal tissue from all of the porcine gastrointestinal tract was extracted and subjected to gel filtration. Glucagon-like peptides were searched for using: 1. a radioimmunoassay which quantifies gut type glucagon (GTG), as well as pancreatic type glucagon (PTG), 2. a radioimmunoassay highly specific for pancreatic type glucagon (PTG), and 3. a radioreceptor assay based on binding of glucagon to porcine liver cell membranes. The oesophageal, the fundic, and the antro-pyloric parts of the gastric mucosa contained very small amounts of GLI. The cardiac gland region contained small amounts of a peptide indistinguishable from "true" glucagon. The duodenal mucosa contained small amounts of "true" glucagon and may be a smaller, glucagon-like peptide. The mucosa of the small intestine contained large amounts of both high and low molecular weight GTG and, in addition, PTG of high molecular weight and "true" glucagon. The colon also contained these components with "true" glucagon in high concentrations. Only small GTG and "true" glucagon were receptor-active, the former with less than its immunometric potency.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 856653     DOI: 10.1007/BF00745145

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  37 in total

1.  Extractable glucagon of the human pancreas.

Authors:  A J KENNY
Journal:  J Clin Endocrinol Metab       Date:  1955-09       Impact factor: 5.958

2.  Increased "glucagon immunoreactivity" in plasma of totally depancreatized dogs.

Authors:  M Vranic; S Pek; R Kawamori
Journal:  Diabetes       Date:  1974-11       Impact factor: 9.461

3.  Enteroglucagon release in the dumping syndrome.

Authors:  S R Bloom; C M Royston; J P Thomson
Journal:  Lancet       Date:  1972-10-14       Impact factor: 79.321

4.  The action of gut glucagon-like immunoreactivity and other intestinal hormones on lipolysis in chicken adipocytes.

Authors:  D R Langslow
Journal:  Horm Metab Res       Date:  1973-11       Impact factor: 2.936

5.  Turkey glucagon: crystallization, amino acid composition and immunology.

Authors:  J Markussen; E Frandsen; L G Heding; F Sundby
Journal:  Horm Metab Res       Date:  1972-09       Impact factor: 2.936

6.  Separation of pancreatic and gut glucagon-like immunoreactivity (G.L.I.) with observations on plasma concentrations of these hormones during lactation.

Authors:  J G Manns
Journal:  Can J Physiol Pharmacol       Date:  1972-06       Impact factor: 2.273

Review 7.  The Banting Memorial Lecture 1975. Diabetes and the alpha cell.

Authors:  R H Unger
Journal:  Diabetes       Date:  1976-02       Impact factor: 9.461

8.  Plasma-glucagon after pancreatectomy.

Authors: 
Journal:  Lancet       Date:  1976-06-12       Impact factor: 79.321

9.  Molecular size of extractable glucagon and glucagon-like immunoreactivity (GLI) in plasma.

Authors:  I Valverde; D Rigopoulou; J Marco; G R Faloona; R H Unger
Journal:  Diabetes       Date:  1970-09       Impact factor: 9.461

10.  Glucagon: role in the hyperglycemia of diabetes mellitus.

Authors:  R Dobbs; H Sakurai; H Sasaki; G Faloona; I Valverde; D Baetens; L Orci; R Unger
Journal:  Science       Date:  1975-02-14       Impact factor: 47.728

View more
  15 in total

1.  Vagal stimulation and its role in eliciting gastrin but not glucagon release from the isolated perfused dog stomach.

Authors:  P J Lefebvre; A S Luyckx; A H Brassinne
Journal:  Gut       Date:  1978-03       Impact factor: 23.059

Review 2.  Glucagon and diabetes: a reappraisal.

Authors:  P J Lefebvre; A S Luyckx
Journal:  Diabetologia       Date:  1979-06       Impact factor: 10.122

3.  Heterogeneity of gastrointestinal hormones.

Authors:  J F Rehfeld
Journal:  World J Surg       Date:  1979-08-31       Impact factor: 3.352

4.  Increased glucose disposal after jejuno-ileostomy.

Authors:  J F Rehfeld; K B Lauritsen; J J Holst
Journal:  Diabetologia       Date:  1979-01       Impact factor: 10.122

5.  Evidence that glicentin contains the entire sequence of glucagon.

Authors:  J J Holst
Journal:  Biochem J       Date:  1980-05-01       Impact factor: 3.857

6.  Glucagon and glicentin immunoreactive cells in human colon.

Authors:  P C Colony; V Helmstaedter; A J Moody; J C Garaud; W G Forssmann
Journal:  Cell Tissue Res       Date:  1982       Impact factor: 5.249

7.  Glucagon- and glicentin-immunoreactive cells in the human digestive tract.

Authors:  J C Garaud; R Eloy; A J Moody; C Stock; J F Grenier
Journal:  Cell Tissue Res       Date:  1980       Impact factor: 5.249

8.  Extrapancreatic glucagon and glucagonlike immunoreactivity in depancreatized dogs. A quantitative assessment of secretion rates and anatomical delineation of sources.

Authors:  W A Muller; L Girardier; J Seydoux; M Berger; A E Renold; M Vranic
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

9.  Glicentin 1-61 probably represents a major fraction of glucagon-related peptides in plasma of anaesthetized uraemic pigs.

Authors:  F G Baldissera; J J Holst
Journal:  Diabetologia       Date:  1986-07       Impact factor: 10.122

10.  Circulating glucagon after total pancreatectomy in man.

Authors:  J J Holst; J H Pedersen; F Baldissera; F Stadil
Journal:  Diabetologia       Date:  1983-11       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.